Advertisement
Original article| Volume 70, 104492, February 2023

Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosis

Published:December 28, 2022DOI:https://doi.org/10.1016/j.msard.2022.104492

      Highlights

      • The scores of FSIQ, VIQ, PIQ, vocabulary, similarities, and digit-symbol in NMOSD and MS patients were lower than the control group.
      • There was no difference between NMOSD and MS groups in IQ scores, except in vocabulary and similarities subsets.
      • A greater EDSS score was associated with decreased scores of FSIQ, VIQ, and PIQ in NMOSD patients.

      Abstract

      Background

      Cognitive impairment is common in people living with neuromyelitis optica spectrum disease (NMOSD) and multiple sclerosis (MS). However, there is little published data on intelligence quotient (IQ) in NMOSD patients. Therefore, we performed the present study to compare IQ scores across NMOSD, MS, and control groups.

      Method

      In this cross-sectional study, 49 NMOSD (30 with positive aquaporin4 antibody), 41 MS, and 20 control individuals were recruited. The IQ score for each person was measured using Wechsler Adult Intelligence Scale-Revised (WAIS-R). Participants were reported on eleven scores of subsets, verbal IQ (VIQ), performance IQ (PIQ), and full score IQ (FSIQ).

      Result

      The scores of FSIQ, VIQ, PIQ, vocabulary, similarities, and digit-symbol in NMOSD and MS individuals were lower than the control group. Relative to control, NMOSD patients reported a lower score of information. We found no difference between NMOSD and MS groups, except in vocabulary and similarities. No significant difference between seropositive and seronegative NMOSD groups was observed except for the information and block design. In NMOSD group, a greater EDSS score was associated with decreased scores of FSIQ, VIQ, and PIQ. Being employed and being married were associated with greater scores of VIQ and PIQ, respectively. In both NMOSD and MS groups, advanced education was associated with increased scores of FSIQ and VIQ.

      Conclusion

      Our study showed decreased IQ scores in NMOSD and MS. Further studies are required to examine intellectual quotient in people with NMOSD and MS.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abedi M.
        [Standardization of Wechsler Adult Intelligence Scale-R (WAIS-R)].
        Psychiatric Institute, Iran University of Medical Sciences, Tehran1994
        • Amato M.
        • Goretti B.
        • Ghezzi A.
        • Lori S.
        • Zipoli V.
        • Portaccio E.
        • Moiola L.
        • Falautano M.
        • De Caro M.
        • Lopez M.
        Cognitive and psychosocial features of childhood and juvenile MS.
        Neurology. 2008; 70: 1891-1897
        • Amato M.
        • Hakiki B.
        • Goretti B.
        • Rossi F.
        • Stromillo M.
        • Giorgio A.
        • Roscio M.
        • Ghezzi A.
        • Guidi L.
        • Bartolozzi M.
        Association of MRI metrics and cognitive impairment in radiologically isolated syndromes.
        Neurology. 2012; 78: 309-314
        • Barzegar M.
        • Badihian S.
        • Mirmosayyeb O.
        • Ashtari F.
        • Jamadi M.
        • Emami S.
        • Jahani L.
        • Safavi A.
        • Shaygannejad V.
        Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: the first report from Iran.
        Mult. Scler. Relat. Disord. 2018; 22: 161-165
        • Barzegar M.
        • Bahmani D.S.
        • Nehzat N.
        • Kiani M.
        • Hashemi N.
        • Mirmosayyeb O.
        • Brand S.
        • Shaygannejad V.
        Comparison of sleep complaints and quality of life between patients with neuromyelitis optica spectrum disorder (NMOSD) and healthy controls.
        Mult. Scler. Relat. Disord. 2019; 32: 81-87
        • Blanc F.
        • Zéphir H.
        • Lebrun C.
        • Labauge P.
        • Castelnovo G.
        • Fleury M.
        • Sellal F.
        • Tranchant C.
        • Dujardin K.
        • Vermersch P.
        Cognitive functions in neuromyelitis optica.
        Arch. Neurol. 2008; 65: 84-88
        • Chanson J.B.
        • Lamy J.
        • Rousseau F.
        • Blanc F.
        • Collongues N.
        • Fleury M.
        • Armspach J.P.
        • Kremer S.
        • de Seze J.
        White matter volume is decreased in the brain of patients with neuromyelitis optica.
        Eur. J. Neurol. 2013; 20: 361-367
        • Chiaravalloti N.D.
        • DeLuca J.
        Cognitive impairment in multiple sclerosis.
        Lancet Neurol. 2008; 7: 1139-1151
        • Cho E.B.
        • Kim D.
        • Jeong B.
        • Shin J.H.
        • Chung Y.H.
        • Kim S.T.
        • Kim B.J.
        • Han C.E.
        • Min J.-H.
        Disrupted structural network of inferomedial temporal regions in relapsing–remitting multiple sclerosis compared with neuromyelitis optica spectrum disorder.
        Sci. Rep. 2022; 12: 1-11
        • Clough M.
        • Bartholomew J.
        • White O.B.
        • Fielding J.
        Working memory phenotypes in early multiple sclerosis: appraisal of phenotype frequency, progression and test sensitivity.
        J. Clin. Med. 2022; 11: 2936
        • Cortese M.
        • Riise T.
        • Bjørnevik K.
        • Bhan A.
        • Farbu E.
        • Grytten N.
        • Hogenesch I.
        • Midgard R.
        • Smith Simonsen C.
        • Telstad W.
        Preclinical disease activity in multiple sclerosis: a prospective study of cognitive performance prior to first symptom.
        Ann. Neurol. 2016; 80: 616-624
        • Deary I.J.
        • Johnson W.
        Intelligence and education: causal perceptions drive analytic processes and therefore conclusions.
        Int. J. Epidemiol. 2010; 39: 1362-1369
        • Fujimori J.
        • Nakashima I.
        • Baba T.
        • Meguro Y.
        • Ogawa R.
        • Fujihara K.
        Cognitive impairment in neuromyelitis optica spectrum disorders: a comparison of the wechsler adult intelligence scale-III and the wechsler memory scale revised with the rao brief repeatable neuropsychological battery.
        Eneurologicalsci. 2017; 9: 3-7
        • Han L.
        • Hong P.
        • Wan Y.
        • Cai L.
        • Shi Z.
        • Wang J.
        • Lang Y.
        • Zhou H.
        Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women.
        Front. Neurol. 2022; 13
        • Kim H.J.
        • Paul F.
        • Lana-Peixoto M.A.
        • Tenembaum S.
        • Asgari N.
        • Palace J.
        • Klawiter E.C.
        • Sato D.K.
        • de Seze J.
        • Wuerfel J.
        MRI characteristics of neuromyelitis optica spectrum disorder: an international update.
        Neurology. 2015; 84: 1165-1173
        • Kim S.-H.
        • Kwak K.
        • Jeong I.H.
        • Hyun J.-W.
        • Jo H.-J.
        • Joung A.
        • Yu E.-S.
        • Kim J.-H.
        • Lee S.H.
        • Yun S.
        Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
        Mult. Scler. J. 2016; 22: 1850-1858
        • Klimova B.
        • Valis M.
        • Kuca K.
        Cognitive decline in normal aging and its prevention: a review on non-pharmacological lifestyle strategies.
        Clin. Interv. Aging. 2017; 12: 903
      1. Kramer, A.F., Bherer, L., Colcombe, S.J., Dong, W., Greenough, W.T. Environmental influences on cognitive and brain plasticity during aging. J. Gerontol. Ser. A: Biological Sciences and Medical Sciences 2004. 59, M940-M957.

        • Kremer S.
        • Renard F.
        • Achard S.
        • Lana-Peixoto M.A.
        • Palace J.
        • Asgari N.
        • Klawiter E.C.
        • Tenembaum S.N.
        • Banwell B.
        • Greenberg B.M.
        Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder.
        JAMA Neurol. 2015; 72: 815-822
        • Kumar S.
        • Gangopadhyay G.
        • Biswas A.
        • Dubey S.
        • Pandit A.
        • Das S.
        • Ray B.K.
        A comparison of cognitive performances between neuromyelitis optica spectrum disorder and multiple sclerosis patients in Indian context.
        Egypt. J. Neurol. Psychiatry Neurosurg. 2021; 57: 1-9
        • Kurtzke J.F.
        Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
        Neurology. 1983; 33 (1444): 1444
        • Lennon V.A.
        • Kryzer T.J.
        • Pittock S.J.
        • Verkman A.
        • Hinson S.R.
        IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
        J. Exp. Med. 2005; 202: 473-477
        • Lennon V.A.
        • Wingerchuk D.M.
        • Kryzer T.J.
        • Pittock S.J.
        • Lucchinetti C.F.
        • Fujihara K.
        • Nakashima I.
        • Weinshenker B.G.
        A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
        Lancet N. Am. Ed. 2004; 364: 2106-2112
        • Liu Y.
        • Fu Y.
        • Schoonheim M.M.
        • Zhang N.
        • Fan M.
        • Su L.
        • Shen Y.
        • Yan Y.
        • Yang L.
        • Wang Q.
        Structural MRI substrates of cognitive impairment in neuromyelitis optica.
        Neurology. 2015; 85: 1491-1499
        • Lysenko E.S.
        • Bogdanova M.D.
        • Arsalidou M.
        Quantitative meta-analyses of cognitive abilities in children with pediatric-onset multiple sclerosis.
        Neuropsychol. Rev. 2022; : 1-15
        • Masuda H.
        • Hirano S.
        • Takahashi N.
        • Hatsugano E.
        • Uzawa A.
        • Uchida T.
        • Ohtani R.
        • Kuwabara S.
        • Mori M.
        Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.
        PLoS One. 2017; 12e0184012
        • Meng H.
        • Xu J.
        • Pan C.
        • Cheng J.
        • Hu Y.
        • Hong Y.
        • Shen Y.
        • Dai H.
        Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis.
        J. Neurol. 2017; 264: 1549-1558
        • Misu T.
        • Fujihara K.
        • Kakita A.
        • Konno H.
        • Nakamura M.
        • Watanabe S.
        • Takahashi T.
        • Nakashima I.
        • Takahashi H.
        • Itoyama Y.
        Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
        Brain. 2007; 130: 1224-1234
        • Moghadasi A.N.
        • Mirmosayyeb O.
        • Mohammadi A.
        • Sahraian M.A.
        • Ghajarzadeh M.
        The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.
        Mult. Scler. Relat. Disord. 2021; 49102757
        • Moore P.
        • Methley A.
        • Pollard C.
        • Mutch K.
        • Hamid S.
        • Elsone L.
        • Jacob A.
        Cognitive and psychiatric comorbidities in neuromyelitis optica.
        J. Neurol. Sci. 2016; 360: 4-9
        • Penke L.
        • Maniega S.M.
        • Bastin M.E.
        • Hernandez V.
        • Murray C.
        • Royle N.A.
        • Starr J.M.
        • Wardlaw J.M.
        • Deary I.J.
        Brain white matter tract integrity as a neural foundation for general intelligence.
        Mol. Psychiatry. 2012; 17: 1026-1030
        • Pietschnig J.
        • Penke L.
        • Wicherts J.M.
        • Zeiler M.
        • Voracek M.
        Meta-analysis of associations between human brain volume and intelligence differences: how strong are they and what do they mean?.
        Neurosci. Biobehav. Rev. 2015; 57: 411-432
        • Pinter D.
        • Sumowski J.
        • DeLuca J.
        • Fazekas F.
        • Pichler A.
        • Khalil M.
        • Langkammer C.
        • Fuchs S.
        • Enzinger C.
        Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis.
        PLoS One. 2014; 9: e87567
        • Pittock S.J.
        • Lennon V.A.
        • Krecke K.
        • Wingerchuk D.M.
        • Lucchinetti C.F.
        • Weinshenker B.G.
        Brain abnormalities in neuromyelitis optica.
        Arch. Neurol. 2006; 63 (a): 390-396
        • Pittock S.J.
        • Weinshenker B.G.
        • Lucchinetti C.F.
        • Wingerchuk D.M.
        • Corboy J.R.
        • Lennon V.A.
        Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
        Arch. Neurol. 2006; 63 (b): 964-968
        • Polman C.H.
        • Reingold S.C.
        • Banwell B.
        • Clanet M.
        • Cohen J.A.
        • Filippi M.
        • Fujihara K.
        • Havrdova E.
        • Hutchinson M.
        • Kappos L.
        Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
        Ann. Neurol. 2011; 69: 292-302
        • Polman C.H.
        • Reingold S.C.
        • Edan G.
        • Filippi M.
        • Hartung H.P.
        • Kappos L.
        • Lublin F.D.
        • Metz L.M.
        • McFarland H.F.
        • O'Connor P.W.
        Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.
        Ann. Neurol. 2005; 58 (Official Journal of the American Neurological Association and the Child Neurology Society): 840-846
        • Reich D.S.
        • Lucchinetti C.F.
        • Calabresi P.A.
        Multiple sclerosis.
        N. Engl. J. Med. 2018; 378 (Jan 11): 169-180https://doi.org/10.1056/NEJMra1401483
        • Roemer S.F.
        • Parisi J.E.
        • Lennon V.A.
        • Benarroch E.E.
        • Lassmann H.
        • Bruck W.
        • Mandler R.N.
        • Weinshenker B.G.
        • Pittock S.J.
        • Wingerchuk D.M.
        Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
        Brain. 2007; 130: 1194-1205
        • Ryan J.J.
        • Gontkovsky S.T.
        • Kreiner D.S.
        • Tree H.A.
        Wechsler adult intelligence scale–Fourth edition performance in relapsing–remitting multiple sclerosis.
        J. Clin. Exp. Neuropsychol. 2012; 34: 571-579
        • Saji E.
        • Arakawa M.
        • Yanagawa K.
        • Toyoshima Y.
        • Yokoseki A.
        • Okamoto K.
        • Otsuki M.
        • Akazawa K.
        • Kakita A.
        • Takahashi H.
        Cognitive impairment and cortical degeneration in neuromyelitis optica.
        Ann. Neurol. 2013; 73: 65-76
        • Schmidt F.A.
        • Chien C.
        • Kuchling J.
        • Bellmann-Strobl J.
        • Ruprecht K.
        • Siebert N.
        • Asseyer S.
        • Jarius S.
        • Brandt A.U.
        • Scheel M.
        Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders: a comparative study.
        Front. Neurol. 2020; 11499910
        • Sehanovic A.
        • Smajlovic D.
        • Tupkovic E.
        • Ibrahimagic O.C.
        • Kunic S.
        • Dostovic Z.
        • Zoletic E.
        • Pasic Z.
        Cognitive disorders in patients with multiple sclerosis.
        Mater. Soc.-Med. 2020; 32: 191
        • Shogren K.A.
        • Turnbull H.R.
        Public policy and outcomes for persons with intellectual disability: extending and expanding the public policy framework of AAIDD's 11th edition of intellectual disability: definition, classification, and systems of support.
        Intell. Dev. Disabil. 2010; 48: 375-386
        • Sinay V.
        • Perez Akly M.
        • Zanga G.
        • Ciardi C.
        • Racosta J.M.
        School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis.
        Mult. Scler. J. 2015; 21: 945-952
        • Sumowski J.F.
        • Rocca M.A.
        • Leavitt V.M.
        • Riccitelli G.
        • Comi G.
        • DeLuca J.
        • Filippi M.
        Brain reserve and cognitive reserve in multiple sclerosis: what you've got and how you use it.
        Neurology. 2013; 80: 2186-2193
        • Thompson A.J.
        • Banwell B.L.
        • Barkhof F.
        • Carroll W.M.
        • Coetzee T.
        • Comi G.
        • Correale J.
        • Fazekas F.
        • Filippi M.
        • Freedman M.S.
        Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
        Lancet Neurol. 2018; 17: 162-173
        • Trahan L.H.
        • Stuebing K.K.
        • Fletcher J.M.
        • Hiscock M.
        The Flynn effect: a meta-analysis.
        Psychol. Bull. 2014; 140: 1332
        • Vanotti S.
        • Cores E.V.
        • Eizaguirre B.
        • Melamud L.
        • Rey R.
        • Villa A.
        Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
        Arq. Neuropsiquiatr. 2013; 71: 357-361
        • Wechsler D.
        Wechsler Adult Intelligence Scale-Revised (WAIS-R).
        Psychological Corporation, 1981
        • Wingerchuk D.M.
        Neuromyelitis optica spectrum disorders.
        Continuum. 2010; 16 (Minneapolis, Minn.)Oct: 105-121https://doi.org/10.1212/01.con.0000389937.69413.15
        • Wingerchuk D.M.
        • Banwell B.
        • Bennett J.L.
        • Cabre P.
        • Carroll W.
        • Chitnis T.
        • De Seze J.
        • Fujihara K.
        • Greenberg B.
        • Jacob A.
        International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
        Neurology. 2015; 85: 177-189
        • Zhang N.
        • Li Y.
        • Fu Y.
        • Shao J.
        • Luo L.
        • Yang L.
        • Shi F.
        • Liu Y.
        Cognitive impairment in Chinese neuromyelitis optica.
        Mult. Scler. J. 2015; 21: 1839-1846